01 256BOEHRINGER INGELHEIM
01 510022379*PED
02 110034877*PED
03 610258637*PED
04 310973827*PED
05 311033552*PED
06 611090323*PED
07 127407955
08 127407955*PED
09 67579449
10 67579449*PED
11 67713938
12 67713938*PED
13 68551957
14 68551957*PED
15 88673927
16 88673927*PED
17 48846695
18 48846695*PED
19 18853156
20 18853156*PED
21 128883805
22 128883805*PED
23 99155705
24 59155705*PED
25 49173859
26 99415016
27 19486526
28 49555001
29 69949998
30 910022379
31 110034877
32 610258637
33 410406172
34 810596120
35 310973827
36 311033552
37 611090323
38 311564886
39 1211833166
40 611911388
41 612115179
42 312178819
43 29173859*PED
44 59415016*PED
45 19486526*PED
46 29555001*PED
47 49949998*PED
01 24Y
02 232Blank
01 91Y
02 165Blank
01 122025-05-02
02 122025-11-02
03 122025-11-26
04 122026-05-26
05 62027-04-15
06 182027-05-04
07 62027-10-15
08 132027-11-04
09 62028-08-01
10 62029-02-01
11 212029-04-02
12 22029-08-05
13 132029-10-02
14 62029-10-14
15 22030-02-05
16 62030-02-11
17 62030-04-10
18 62030-04-14
19 92030-05-21
20 42030-06-04
21 42030-06-15
22 52030-11-21
23 42030-12-04
24 12031-03-05
25 12031-09-05
26 112032-03-07
27 42033-03-06
28 22033-09-06
29 242034-04-03
30 62034-06-11
31 122034-10-03
32 42034-12-11
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2031-03-05
US Patent Number : 8853156
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201280
Patent Use Code : U-1642
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2031-03-05
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201280
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1967
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1968
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2030-06-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8846695
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2030-06-04
